A clinical trial now open at UW Health | Carbone Cancer Center uses a patient’s dying tumor cells to try to teach their immune system to find and destroy cancer cells following surgery for a type of brain cancer called glioblastoma....
In the span of two months, Sezar went from playing soccer with his siblings to becoming the first patient to receive a transplant through the pediatric heart transplant program at the UW Health Transplant Center....
A protective mineral coating identified by University of Wisconsin–Madison biomedical engineering researchers could allow powerful messenger RNA therapeutics like COVID-19 vaccines to be stored at room temperature, making them more accessible to lower-resourced communities across the world....
Patients at UW Health could now receive messages directly in MyChart inviting them to participate in health research. This year, patients who have access to their MyChart accounts might have noticed a new tab on their profile labeled “Research,” according to Dr. Mike Semanik, physician...
Elizabeth Hagerman, chief innovation officer at UW Health and executive director of the Isthmus Project, discusses her background and the Isthmus Project's efforts to help UW- and UW Health-affiliated entrepreneurs take healthcare innovations through the commercialization process....
The University of Wisconsin–Madison is rolling out a new system to make payment to research participants easier and more efficient....
Lauren W. Yowelunh McLester-Davis, a University of Wisconsin–Madison neuroscientist and researcher, has joined the Native American Center for Health Professions (NACHP) in the UW School of Medicine and Public Health as its first director of Indigenous science advocacy....
A research study at UW–Madison School of Medicine and Public Health is investigating a drug that could one day prevent Alzheimer’s disease....
Researchers at the University of Wisconsin School of Medicine and Public Health are exploring the ideal vaccine booster strategy for immunosuppressed patients to protect those at higher risk of severe illness and complications from COVID-19 infection....
DeSantes, a UW Carbone Cancer Center researcher and Medical Director for the Pediatric Bone Marrow Transplant and Cell Therapy program, said this phase I-II clinical trial uses a variation of an existing immunotherapy drug as part of a combination therapy for neuroblastoma patients who have advanced...
